H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 100 Citations 36,776 322 World Ranking 263 National Ranking 5
Medicine D-index 103 Citations 38,206 353 World Ranking 3227 National Ranking 40

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Gene
  • Antigen

Martin F. Bachmann mainly investigates Immunology, Cytotoxic T cell, Antigen, Immune system and Virus. He has included themes like CD8 and Cell biology in his Cytotoxic T cell study. His study in Antigen is interdisciplinary in nature, drawing from both Titer, Antibody and B cell.

His Immune system study incorporates themes from Proinflammatory cytokine and Disease. His Virus research is multidisciplinary, incorporating perspectives in Immunodeficiency, IRF8, Immunogenicity and Vaccination. His Virology research incorporates elements of Antibody response and Cytotoxicity.

His most cited work include:

  • mTOR regulates memory CD8 T-cell differentiation (1090 citations)
  • Disruption of the murine IL-4 gene blocks Th2 cytokine responses (1069 citations)
  • Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns (1064 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Immunology, Immune system, Antigen, Virology and Antibody. His research is interdisciplinary, bridging the disciplines of Cytotoxic T cell and Immunology. Martin F. Bachmann interconnects T cell, CD8 and Cell biology in the investigation of issues within Cytotoxic T cell.

His Immune system study frequently involves adjacent topics like Adjuvant. His work is dedicated to discovering how Antigen, B cell are connected with B-1 cell and Naive B cell and other disciplines. The concepts of his Virology study are interwoven with issues in CTL*, Recombinant DNA and Oligonucleotide.

He most often published in these fields:

  • Immunology (53.94%)
  • Immune system (35.04%)
  • Antigen (29.13%)

What were the highlights of his more recent work (between 2018-2021)?

  • Immunology (53.94%)
  • Antibody (24.61%)
  • Vaccination (20.08%)

In recent papers he was focusing on the following fields of study:

Immunology, Antibody, Vaccination, Immune system and Virology are his primary areas of study. Martin F. Bachmann works mostly in the field of Immunology, limiting it down to topics relating to In vivo and, in certain cases, Monoclonal, as a part of the same area of interest. His work deals with themes such as Adjuvant and Antigen, which intersect with Immune system.

His studies in Antigen integrate themes in fields like Cytotoxic T cell, Lymphatic system and Computational biology. His Cytotoxic T cell study combines topics in areas such as T cell and CD8. His work carried out in the field of Virology brings together such families of science as Virus-Like Particle Vaccines and Serology.

Between 2018 and 2021, his most popular works were:

  • Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens. (27 citations)
  • Virus-like particles for vaccination against cancer. (25 citations)
  • Virus-like particles for vaccination against cancer. (25 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Antibody

His main research concerns Immunology, Vaccination, Adjuvant, Immune system and Antigen. His Immunology research includes themes of Peripheral blood mononuclear cell and Disease. The Vaccination study combines topics in areas such as Interleukin 31, Cancer, Therapeutic vaccine and Antibody.

The various areas that Martin F. Bachmann examines in his Immune system study include Virus and Clinical trial, Bioinformatics. As part of one scientific family, Martin F. Bachmann deals mainly with the area of Antigen, narrowing it down to issues related to the Cell biology, and often Innate immune system, Virus-like particle, Spleen, Nucleic acid and Glycan. His Immunogenicity research includes elements of Cytotoxic T cell, Cancer research and T cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Disruption of the murine IL-4 gene blocks Th2 cytokine responses

M Kopf;G Le Gros;M Bachmann;M C Lamers.
Nature (1993)

1394 Citations

mTOR regulates memory CD8 T-cell differentiation

Koichi Araki;Alexandra P. Turner;Virginia Oliva Shaffer;Shivaprakash Gangappa.
Nature (2009)

1218 Citations

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

Martin F. Bachmann;Gary T. Jennings.
Nature Reviews Immunology (2010)

1202 Citations

Nanoparticles target distinct dendritic cell populations according to their size

Vania Manolova;Anna Flace;Monika Bauer;Katrin Schwarz.
European Journal of Immunology (2008)

880 Citations

On immunological memory.

Rolf M. Zinkernagel;Martin F. Bachmann;Thomas M. Kündig;Stephan Oehen.
Annual Review of Immunology (1996)

880 Citations

The influence of antigen organization on B cell responsiveness

Martin F. Bachmann;Urs Hoffmann Rohrer;Thomas M. Kundig;Kurt Burki.
Science (1993)

703 Citations

Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene

Thomas Holtschke;Jürgen Löhler;Yuka Kanno;Thomas Fehr.
Cell (1996)

671 Citations

SELECTION OF THE T CELL REPERTOIRE

Eric Sebzda;Sanjeev Mariathasan;Toshiaki Ohteki;Russell Jones.
Annual Review of Immunology (1999)

637 Citations

Immune responses in interleukin-2-deficient mice

Thomas M. Kundig;Hubert Schorle;Martin F. Bachmann;Hans Hengartner.
Science (1993)

533 Citations

Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation

Martin F Bachmann;Kim McKall-Faienza;Rudolf Schmits;Rudolf Schmits;Denis Bouchard.
Immunity (1997)

499 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Martin F. Bachmann

Rolf M. Zinkernagel

Rolf M. Zinkernagel

University of Zurich

Publications: 121

Hans Hengartner

Hans Hengartner

University of Zurich

Publications: 95

Rafi Ahmed

Rafi Ahmed

Emory University

Publications: 93

Richard A. Flavell

Richard A. Flavell

Yale University

Publications: 76

Pamela S. Ohashi

Pamela S. Ohashi

Princess Margaret Cancer Centre

Publications: 75

Manfred Kopf

Manfred Kopf

ETH Zurich

Publications: 71

Tak W. Mak

Tak W. Mak

Princess Margaret Cancer Centre

Publications: 67

Josef M. Penninger

Josef M. Penninger

University of British Columbia

Publications: 62

Michael L. Dustin

Michael L. Dustin

University of Oxford

Publications: 53

Susan M. Kaech

Susan M. Kaech

Salk Institute for Biological Studies

Publications: 53

Arlene H. Sharpe

Arlene H. Sharpe

Harvard University

Publications: 53

Burkhard Ludewig

Burkhard Ludewig

Kantonsspital St. Gallen

Publications: 52

Annette Oxenius

Annette Oxenius

ETH Zurich

Publications: 51

Keiko Ozato

Keiko Ozato

National Institutes of Health

Publications: 51

Bernhard Odermatt

Bernhard Odermatt

University of Zurich

Publications: 49

Shane Crotty

Shane Crotty

La Jolla Institute For Allergy & Immunology

Publications: 47

Something went wrong. Please try again later.